Detail akcie Sanuwave Health online

Business Summary: Sanuwave Health, Inc. is an ultrasound and shock wave technology company. The Company is a provider of Food and Drug Administration (FDA)-approved wound care products. It is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. The Company applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and others. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing from within. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression (PACE) technology to converge at precise selected targets to produce an extremely short duration compression burst.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, SANUWAVE Health Inc revenues increased 22% to $20.4M. Net loss increased from $10.3M to $25.8M. Revenues reflect United States segment increase of 32% to $20.2M. Higher net loss reflects Gain/Loss on Derivatives - Hedging decrease from $16.7M (income) to $9.6M (expense), Interest expense, related party increase of 97% to $2.7M (expense).